GUANGZHOU, China – The Department of Consumer Goods Industry under China's Ministry of Industry and Information Technology (MIIT) has recently released the "Unveiling and Benchmarking" initiative list for high-performance bioreactors, naming the selected entities. The "Parallel Bioreactors for Cell Culture" project, submitted by a consortium led by Applitech Biological Technology Co., Ltd. has been successfully selected after a rigorous multi-stage evaluation. The project partners include the Institute of Process Engineering of the Chinese Academy of Sciences, CNBG Institute of Biological Technology Co., Ltd., and Hangzhou Borui Biopharmaceutical Co., Ltd., following a merit-based recommendation from the Guangdong Provincial Department of Industry and Information Technology and subsequent screenings organized by MIIT.

This selection marks the first time Applitech Biological Technology Co., Ltd. has been included as a lead unit in a national-level major innovation task. This achievement recognizes the company's strong technical capabilities and showcases its comprehensive competitiveness in the field of bio-manufacturing equipment. It signifies a major leap forward for Applitech in bioreactor R&D capabilities, organizational strength, and collaborative innovation.
This successful selection marks a key milestone in Applitech's bioreactor development. Together with our project partners, we will diligently execute the MIIT's guidance to successfully complete these innovation tasks. Our goal is to provide solid support for advancing China's biopharmaceutical and bio-manufacturing sectors.